Scalable Life Sciences supports Bavarian Nordic in the areas of market acces en public affairs.
Bavarian Nordic is an international biotechnology company developing and
manufacturing novel cancer
immunotherapies and vaccines for infectious diseases.
Bavarian Nordic focuses on developing product candidates to address
cancer and infectious diseases
by leveraging several core strengths: